Table 1.

Baseline characteristics of evaluable high-risk women

Patient Characteristics	Intervention (N=141)		Control (N=141)		Total (N=282)
Age, years
Mean (SD)	58.43 (10.40)		56.42 (9.22)		57.43 (9.86)
Menopausal status, N (%)
Pre/Perimenopausal	54	38.3%	58	41.1%	112	39.7%
Postmenopausal	87	61.7%	83	58.9%	170	60.3%
Race/ethnicity, N (%)
Non-Hispanic White	80	56.7%	85	60.3%	165	58.5%
Non-Hispanic Black	19	13.5%	21	14.9%	40	14.2%
Hispanic	33	23.4%	26	18.4%	59	20.9%
Other	9	6.4%	9	6.4%	18	6.4%
Highest Level of Education, N (%)
High school or less	25	17.7%	18	12.8%	43	15.2%
Some college or bachelors	51	36.2%	53	37.6%	104	36.9%
Graduate or professional degree	46	32.6%	52	36.9%	98	34.8%
Unknown	19	13.5%	18	12.8%	37	13.1%
Benign breast disease, N (%)	97	68.8%	91	64.5%	188	66.7%
Atypical hyperplasia	29	20.6%	31	22.0%	60	21.3%
Lobular carcinoma in situ (LCIS)	4	2.8%	11	7.8%	15	5.3%
First-degree family history of breast cancer, N (%)	84	59.6%	96	68.0%	180	63.8%
Age of menarche, N (%)
7-11 years	36	25.5%	36	25.5%	72	25.5%
12-13 years	76	53.9%	77	54.6%	153	54.3%
14+ years	27	19.1%	27	19.1%	54	19.1%
Unknown	2	1.4%	1	0.7%	3	1.1%
Age of first birth, N (%)
No births	41	29.1%	33	23.4%	74	26.2%
<20 years	13	9.2%	24	17.0%	37	13.1%
20-24 years	22	15.6%	19	13.5%	41	14.5%
25-29 years	17	12.1%	17	12.1%	34	12.1%
30+ years	48	34.0%	48	34.0%	96	34.0%
* 5-year invasive breast cancer risk, %
Mean (SD)	2.95 (1.53)		3.00 (1.30)		2.98 (1.42)
* Lifetime invasive breast cancer risk, %
Mean (SD)	15.81 (9.26)		17.48 (8.08)		16.64 (8.72)
Adequate health literacy, N (%)	115	83.3%	118	83.7%	233	83.2%
Mean subjective numeracy (SD) [range, 1-6]	4.08 (1.42)		4.13 (1.54)		4.11 (1.48)
Mean acculturation (SD) [range, 1-5]	3.81 (1.69)		4.03 (1.56)		3.92 (1.63)

^*Calculated according to the Gail breast cancer risk assessment tool, excluding women with a history of lobular carcinoma in situ